Results about: bioinformatics

Exascale computation to transform research and industry in less than ten years

Exascale computation, to be available as of 2020, will achieve a rate of one trillion calculations per second, making it 1000 times faster than today’s most powerful supercomputers.

This will lead to a wealth of benefits for science and economy: it will allow scientists to read, process and better understand the genome, produce drugs more cheaply, and create computer simulations of entire organisms, including humans, which will provide an important boost to personalized medicine.

On 18-20 September, experts from the US, Canada, Germany, Switzerland, the UK, Germany and Spain will meet at Barcelona’s Cosmocaixa to discuss the current state and expectations of high-throughput supercomputing, and its impact on European research and industry.

A 6-million euro European project to study stem cell aging

• Headed by EMBL in Germany, the consortium “SyStemAge” seeks to identify the molecular mechanisms behind aging and the consequences of this process, and also to propose biomarkers to combat age-related diseases.

• The consortium involves clinical researchers, biologists specialized in two types of blood cancer, systems biologists, and biotech managers.

Patrick Aloy, researcher at IRB Barcelona, will integrate the biological and clinical data to build dynamic maps of genes and proteins involved in the processes addressed in this study.